Description
The Ensign Group Turns 85.1% Transitioning Occupancy Into Acquisition Momentum!
The Ensign Group, Inc. reported financial and operational results for the first quarter of 2026 that reflect continued growth amid supportive industry dynamics and ongoing strategic acquisitions. The company emphasized strong operational performance with record same-store and transitioning occupancy levels of 84.3% and 85.1%, respectively, alongside increases in skilled mix days and Medicare revenue by approximately 5-10% compared to the prior year. Ensign highlighted sustained clinical excellence as a core driver, with 85% of operations rated 4- or 5-star by CMS quality measures, significantly outperforming state and national peers, which contributes to solid referral relationships and revenue growth. The company’s diversified footprint across payers, geographies, and referral sources appears to mitigate risks associated with payer-specific volume fluctuations or tightened clinical reviews.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!



